Skip to main content

Table 3 Total hip arthroplasty in hospital outcomes

From: Epidemiology of total hip arthroplasty: demographics, comorbidities and outcomes

THA

rTHA

 

Discharges (n = 2,838,742)

 

Discharges (n = 400,974)

Any Complications

775,599 (27.32%)

Any Complication

158,235 (39.46%)

Postoperative Anemia

730,134 (25.72%)

Postoperative Anemia

143,120 (35.69%)

Hematoma/Seroma

22,521 (0.79%)

Hematoma/Seroma

11,539 (2.88%)

Cardiac Complication

19,042 (0.67%)

Postoperative Infection

4,337 (1.11%)

Genitourinary Complication

16,046 (0.57%)

Wound Dehiscence

4,194 (1.05%)

Gastrointestinal Complication

9,198 (0.32%)

Cardiac Complication

3,806 (0.95%)

Deep Vein Thrombosis

5,752 (0.20%)

Died During Hospitalization

3,127 (0.78%)

Pulmonary Embolism

5,348 (0.16%)

Deep Vein Thrombosis

3,034 (0.76%)

Respiratory Complication

4,556 (0.16%)

Genitourinary Complication

2,358 (0.59%)

Died During Hospitalization

4,234 (0.15%)

Respiratory Complication

1,870 (0.47%)

Postoperative Infection

3,246 (0.11%)

Pulmonary Embolism

1,589 (0.40%)

Wound Dehiscence

1,903 (0.07%)

Gastrointestinal Complication

1,511 (0.38%)

Peripheral Vascular Disease Complication

1,242 (0.04%)

Peripheral Vascular Disease Complication

369 (0.09%)

Total Charges, $, (Standard Error)

$53,324 ($478)

Total Charges, $, (Standard Error)

$75,037 ($901)

Length of Stay, Days, (Standard Error)

3.30 (0.01)

Length of Stay, Days, (Standard Error)

5.37 (0.04)

  1. In hospital outcomes collected from the NIS database of patients undergoing THA and rTHA from 2006 to the third quarter of 2015